Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Cegedim

Market Cap 157M 180M 146M 137M 256M 17.02B 257M 1.73B 669M 8.37B 677M 662M 29.11B P/E 2026 *
7.8x
P/E 2027 * 5.19x
Enterprise Value 336M 385M 311M 291M 545M 36.3B 548M 3.68B 1.43B 17.84B 1.44B 1.41B 62.06B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.45x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-56.91%
1 week+4.20%
Current month+4.20%
1 month+11.47%
3 months+32.35%
6 months-7.25%
Current year-9.33%
1 week 11.32
Extreme 11.32
12.15
1 month 11.3
Extreme 11.3
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
23.29
5 years 8.6
Extreme 8.6
29.75
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+4.20% - - 180M
+0.41%+0.09%-10.18%+51.01% 530B
-0.53%-4.36%-46.59%+7.67% 180B
-0.46%-6.96%-51.08%-15.07% 98.02B
+0.82%-5.18%-42.57%+2.87% 41.44B
-3.46%-9.23%-69.56%+259.06% 39.57B
-2.69%-7.01%-39.25%+37.83% 25.43B
+1.02%-0.64%-41.77%+13.96% 14.3B
+0.59%-2.50%-31.54%-4.69% 11.46B
+1.22%-0.71%-35.30%-7.87% 9.7B
Average -6.00%-3.73%-40.87%+38.31% 105.51B
Weighted average by Cap. -0.08%-2.29%-26.94%+40.37%

Financials

2026 *2027 *
Net sales 660M 757M 611M 573M 1.07B 71.45B 1.08B 7.25B 2.81B 35.11B 2.84B 2.78B 122B 681M 781M 631M 592M 1.11B 73.7B 1.11B 7.48B 2.89B 36.21B 2.93B 2.87B 126B
Net income 21.25M 24.36M 19.67M 18.45M 34.51M 2.3B 34.71M 233M 90.3M 1.13B 91.47M 89.4M 3.93B 30.58M 35.06M 28.31M 26.56M 49.67M 3.31B 49.96M 336M 130M 1.63B 132M 129M 5.66B
Net Debt 178M 204M 165M 155M 289M 19.27B 291M 1.96B 757M 9.47B 767M 749M 32.95B 150M 172M 139M 130M 243M 16.2B 245M 1.64B 636M 7.96B 645M 630M 27.7B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
11.46EUR
Average target price
15.00EUR
Spread / Average Target
+30.89%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!